Literature DB >> 1755783

Immunisation against ovine caseous lymphadenitis: correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined clostridial-corynebacterial vaccines.

D G Eggleton1, J A Haynes, H D Middleton, J C Cox.   

Abstract

Groups of sheep were dosed with vaccines containing Corynebacterium pseudotuberculosis toxoid combined in varying amounts with 5 clostridial antigens. Resistance of the sheep to infection with C pseudotuberculosis was tested at 1, 6 and 12 months after vaccination by infection with pus from ovine lymph glands actively infected with C pseudotuberculosis. The outcome was assessed 3 months after challenge by slaughter and inspection of the sheep for caseous lymphadenitis lesions. Protection was demonstrated by a significant reduction in the proportion of immunised sheep exhibiting lesions compared with control sheep, and by fewer abscesses in affected immunised sheep than in affected control sheep. A positive correlation was found between amount of C pseudotuberculosis toxoid administered and degree of protection obtained. Chromatographically-purified toxoid induced essentially the same protection, suggesting that anti-toxic immunity is the major factor in protection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755783     DOI: 10.1111/j.1751-0813.1991.tb03088.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  7 in total

1.  Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.

Authors:  P J Chaplin; R De Rose; J S Boyle; P McWaters; J Kelly; J M Tennent; A M Lew; J P Scheerlinck
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep.

Authors:  C P Simmons; S J Dunstan; M Tachedjian; J Krywult; A L Hodgson; R A Strugnell
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines.

Authors:  K Stanford; K A Brogden; L A McClelland; G C Kozub; F Audibert
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

4.  Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis.

Authors:  A L Hodgson; M Tachedjian; L A Corner; A J Radford
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Identification of a novel antigen from Corynebacterium pseudotuberculosis that protects sheep against caseous lymphadenitis.

Authors:  J Walker; H J Jackson; D G Eggleton; E N Meeusen; M J Wilson; M R Brandon
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Vaccination against Corynebacterium pseudotuberculosis infections controlling caseous lymphadenitis (CLA) and oedematousskin disease.

Authors:  Ihab M Moussa; Mohamed S Ali; Ashgan M Hessain; Saleh A Kabli; Hassan A Hemeg; Salha Abdelkareem Selim
Journal:  Saudi J Biol Sci       Date:  2016-06-17       Impact factor: 4.219

7.  Humoral and cellular immune responses in mice against secreted and somatic antigens from a Corynebacterium pseudotuberculosis attenuated strain: Immune response against a C. pseudotuberculosis strain.

Authors:  Vera Lúcia Costa Vale; Marcos da Costa Silva; Andréia Pacheco de Souza; Soraya Castro Trindade; Lília Ferreira de Moura-Costa; Ellen Karla Nobre Dos Santos-Lima; Ivana Lucia de Oliveira Nascimento; Hugo Saba Pereira Cardoso; Edson de Jesus Marques; Bruno Jean Adrien Paule; Roberto José Meyer Nascimento
Journal:  BMC Vet Res       Date:  2016-09-08       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.